{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T09:39:26Z","timestamp":1772012366665,"version":"3.50.1"},"reference-count":57,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,3]],"date-time":"2022-11-03T00:00:00Z","timestamp":1667433600000},"content-version":"vor","delay-in-days":1889,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100008322","name":"CSL Behring","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004702","name":"Baxter International","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004702","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1111\/jth.13778","type":"journal-article","created":{"date-parts":[[2017,7,11]],"date-time":"2017-07-11T09:56:43Z","timestamp":1499767003000},"page":"1788-1798","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["A fusion protein of interleukin\u20104 and interleukin\u201010 protects against blood\u2010induced cartilage damage in vitro and in vivo"],"prefix":"10.1016","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3242-5524","authenticated-orcid":false,"given":"L.F.D.","family":"van Vulpen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Popov\u2010Celeketic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.E.R.","family":"van Meegeren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Coeleveld","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.M.","family":"van Laar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.E.","family":"Hack","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.E.G.","family":"Schutgens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.C.","family":"Mastbergen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.P.J.G.","family":"Lafeber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1111\/jth.13778_bb0010","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1111\/j.1365-2516.2012.02909.x","article-title":"Guidelines for the management of hemophilia","volume":"19","author":"Srivastava","year":"2013","journal-title":"Haemophilia"},{"key":"10.1111\/jth.13778_bb0015","doi-asserted-by":"crossref","first-page":"62","DOI":"10.12968\/hmed.2008.69.8.30743","article-title":"Assessment and management of posttraumatic haemarthrosis of the knee","volume":"69","author":"Shaerf","year":"2008","journal-title":"Br J Hosp Med (Lond)"},{"key":"10.1111\/jth.13778_bb0020","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.knee.2009.06.008","article-title":"Recurrent haemarthrosis following total knee replacement","volume":"17","author":"Saksena","year":"2010","journal-title":"Knee"},{"key":"10.1111\/jth.13778_bb0025","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1055\/s-0038-1657358","article-title":"Hemarthroses and warfarin: joint destruction with anticoagulation","volume":"49","author":"Andes","year":"1983","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.13778_bb0030","first-page":"339","article-title":"Blood\u2010induced joint damage: longterm effects in vitro and in vivo","volume":"30","author":"Hooiveld","year":"2003","journal-title":"J Rheumatol"},{"key":"10.1111\/jth.13778_bb0035","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1111\/j.1365-2516.2008.01689.x","article-title":"Experimental haemophilic arthropathy in a mouse model of a massive haemarthrosis: gross, radiological and histological changes","volume":"14","author":"Hakobyan","year":"2008","journal-title":"Haemophilia"},{"key":"10.1111\/jth.13778_bb0040","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.joca.2008.09.001","article-title":"Very rapid clearance after a joint bleed in the canine knee cannot prevent adverse effects on cartilage and synovial tissue","volume":"17","author":"Jansen","year":"2009","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1111\/jth.13778_bb0045","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1055\/s-2003-37938","article-title":"Blood\u2010induced joint damage in hemophilia","volume":"29","author":"Roosendaal","year":"2003","journal-title":"Semin Thromb Hemost"},{"key":"10.1111\/jth.13778_bb0050","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/j.1365-2516.2010.02450.x","article-title":"Trends in bleeding patterns during prophylaxis for severe haemophilia: observations from a series of prospective clinical trials","volume":"17","author":"Fischer","year":"2011","journal-title":"Haemophilia"},{"issue":"Suppl. 1","key":"10.1111\/jth.13778_bb0055","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1046\/j.1365-2516.1999.0050s1005.x","article-title":"Therapeutic options in the management of articular contractures in haemophiliacs","volume":"5","author":"Rodriguez\u2010Merchan","year":"1999","journal-title":"Haemophilia"},{"issue":"Suppl. 1","key":"10.1111\/jth.13778_bb0060","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1046\/j.1365-2516.1999.0050s1016.x","article-title":"Physiotherapy for the treatment of articular contractures in haemophilia","volume":"5","author":"Heijnen","year":"1999","journal-title":"Haemophilia"},{"issue":"Suppl. 4","key":"10.1111\/jth.13778_bb0065","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1365-2516.2008.01734.x","article-title":"Management of haemophilic arthropathy","volume":"14","author":"Bossard","year":"2008","journal-title":"Haemophilia"},{"key":"10.1111\/jth.13778_bb0070","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1111\/j.1538-7836.2010.03962.x","article-title":"Blood\u2010induced joint disease: the pathophysiology of hemophilic arthropathy","volume":"8","author":"Valentino","year":"2010","journal-title":"J Thromb Haemost"},{"issue":"Suppl. 4","key":"10.1111\/jth.13778_bb0075","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1365-2516.2008.01732.x","article-title":"Physiopathology of haemophilic arthropathy","volume":"14","author":"Lafeber","year":"2008","journal-title":"Haemophilia"},{"key":"10.1111\/jth.13778_bb0080","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1111\/j.1365-2141.2008.07386.x","article-title":"Understanding haemophilic arthropathy: an exploration of current open issues","volume":"143","author":"Jansen","year":"2008","journal-title":"Br J Haematol"},{"key":"10.1111\/jth.13778_bb0085","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1093\/rheumatology\/keg220","article-title":"Haemoglobin\u2010derived iron\u2010dependent hydroxyl radical formation in blood\u2010induced joint damage: an in vitro study","volume":"42","author":"Hooiveld","year":"2003","journal-title":"Rheumatology (Oxford)"},{"key":"10.1111\/jth.13778_bb0090","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.joca.2012.04.002","article-title":"IL\u20104 alone and in combination with IL\u201010 protects against blood\u2010induced cartilage damage","volume":"20","author":"van Meegeren","year":"2012","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1111\/jth.13778_bb0095","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1093\/rheumatology\/ket005","article-title":"A short time window to profit from protection of blood\u2010induced cartilage damage by IL\u20104 plus IL\u201010","volume":"52","author":"van Meegeren","year":"2013","journal-title":"Rheumatology (Oxford)"},{"key":"10.1111\/jth.13778_bb0100","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/bjh.12148","article-title":"A single intra\u2010articular injection with IL\u20104 plus IL\u201010 ameliorates blood\u2010induced cartilage degeneration in haemophilic mice","volume":"160","author":"van Meegeren","year":"2013","journal-title":"Br J Haematol"},{"key":"10.1111\/jth.13778_bb0105","doi-asserted-by":"crossref","first-page":"9558","DOI":"10.1074\/jbc.270.16.9558","article-title":"Interleukin (IL)\u201010 inhibits nuclear factor kappa B (NF kappa B) activation in human monocytes. IL\u201010 and IL\u20104 suppress cytokine synthesis by different mechanisms","volume":"270","author":"Wang","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1111\/jth.13778_bb0110","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/1529-0131(200101)44:1<3::AID-ANR2>3.0.CO;2-U","article-title":"Synergistic activity of interleukin\u20104 and interleukin\u201010 in suppression of inflammation and joint destruction in rheumatoid arthritis","volume":"44","author":"van Roon","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1111\/jth.13778_bb0115","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/art.1780400209","article-title":"Role of interleukin\u20104 and interleukin\u201010 in murine collagen\u2010induced arthritis. Protective effect of interleukin\u20104 and interleukin\u201010 treatment on cartilage destruction","volume":"40","author":"Joosten","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1111\/jth.13778_bb0120","doi-asserted-by":"crossref","first-page":"7353","DOI":"10.1523\/JNEUROSCI.0092-16.2016","article-title":"IL4\u201010 fusion protein is a novel drug to treat persistent inflammatory pain","volume":"36","author":"Eijkelkamp","year":"2016","journal-title":"J Neurosci"},{"key":"10.1111\/jth.13778_bb0125","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2015-eular.4856","article-title":"IL4\u201010 synerkine induces direct and indirect structural cartilage repair in OA [abstract]","volume":"74","author":"Pustjens","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1111\/jth.13778_bb0130","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1002\/1529-0131(199905)42:5<1025::AID-ANR23>3.0.CO;2-3","article-title":"Blood\u2010induced joint damage: a human in vitro study","volume":"42","author":"Roosendaal","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1111\/jth.13778_bb0135","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1111\/hae.12950","article-title":"Haemarthrosis model in mice: BSS \u2010 Bleeding Severity Score assessment system","volume":"22","author":"Hakobyan","year":"2016","journal-title":"Haemophilia"},{"key":"10.1111\/jth.13778_bb0140","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/jth.12467","article-title":"Antiplasmin, but not amiloride, prevents synovitis and cartilage damage following hemarthrosis in hemophilic mice","volume":"12","author":"Nieuwenhuizen","year":"2014","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.13778_bb0145","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/hae.12532","article-title":"The biological efficacy profile of BAX 855, a PEGylated recombinant factor VIII molecule","volume":"21","author":"Valentino","year":"2015","journal-title":"Haemophilia"},{"key":"10.1111\/jth.13778_bb0150","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1111\/j.1365-2516.2006.01348.x","article-title":"Histological changes in murine haemophilic synovitis: a quantitative grading system to assess blood\u2010induced synovitis","volume":"12","author":"Valentino","year":"2006","journal-title":"Haemophilia"},{"issue":"Suppl. 3","key":"10.1111\/jth.13778_bb0155","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1016\/j.joca.2010.05.025","article-title":"The OARSI histopathology initiative \u2010 recommendations for histological assessments of osteoarthritis in the mouse","volume":"18","author":"Glasson","year":"2010","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1111\/jth.13778_bb0160","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1160\/th14-01-0029","article-title":"Deferasirox limits cartilage damage following haemarthrosis in haemophilic mice","volume":"112","author":"Nieuwenhuizen","year":"2014","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.13778_bb0165","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1002\/art.1780390516","article-title":"Prevention and reversal of cartilage degradation in rheumatoid arthritis by interleukin\u201010 and interleukin\u20104","volume":"39","author":"van Roon","year":"1996","journal-title":"Arthritis Rheum"},{"key":"10.1111\/jth.13778_bb0170","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/ar14","article-title":"Protection against cartilage and bone destruction by systemic interleukin\u20104 treatment in established murine type II collagen\u2010induced arthritis","volume":"1","author":"Joosten","year":"1999","journal-title":"Arthritis Research"},{"key":"10.1111\/jth.13778_bb0175","first-page":"S56","article-title":"rHuIL\u20104 in subjects with active rheumatoid arthritis: a phase I dose escalating safety study [abstract]","volume":"41","author":"Van den Bosch","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1111\/jth.13778_bb0180","first-page":"S224","article-title":"rHuIL\u201010 in subjects with active rheumatoid arthritis: a phase I and cytokine response study [abstract]","volume":"40","author":"Maini","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1111\/jth.13778_bb0185","doi-asserted-by":"crossref","first-page":"5492","DOI":"10.4049\/jimmunol.154.10.5492","article-title":"A randomized, controlled trial of IL\u201010 in humans. Inhibition of inflammatory cytokine production and immune responses","volume":"154","author":"Chernoff","year":"1995","journal-title":"J Immunol"},{"key":"10.1111\/jth.13778_bb0190","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0009-9236(97)90065-5","article-title":"Pharmacodynamics of subcutaneous recombinant human interleukin\u201010 in healthy volunteers","volume":"62","author":"Huhn","year":"1997","journal-title":"Clin Pharmacol Ther"},{"key":"10.1111\/jth.13778_bb0195","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1182\/blood.V87.2.699.bloodjournal872699","article-title":"Pharmacokinetics and immunomodulatory properties of intravenously administered recombinant human interleukin\u201010 in healthy volunteers","volume":"87","author":"Huhn","year":"1996","journal-title":"Blood"},{"key":"10.1111\/jth.13778_bb0200","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1023\/A:1011918425629","article-title":"Pharmacokinetics and leukocyte responses of recombinant human interleukin\u201010","volume":"15","author":"Radwanski","year":"1998","journal-title":"Pharm Res"},{"key":"10.1111\/jth.13778_bb0205","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1016\/0959-8049(93)90108-R","article-title":"Recombinant human interleukin\u20104 (rhu IL\u20104) administered by the intravenous and subcutaneous routes in patients with advanced cancer\u2013a phase I toxicity study and pharmacokinetic analysis","volume":"29A","author":"Prendiville","year":"1993","journal-title":"European journal of cancer (Oxford, England: 1990)"},{"key":"10.1111\/jth.13778_bb0210","unstructured":"Van Roon JAG, Hartgring SAY, Hack CE, Steen\u2010Louws C, Lafeber FPJG. Fusion protein comprising an interleukin 4 and interleukin 10. Patent EP2776460 owned by UMC Utrecht Holding BV."},{"key":"10.1111\/jth.13778_bb0215","first-page":"1763","article-title":"IL4\u201310 synerkine: a novel immunoregulatory drug to prevent immunopathology in rheumatic diseases [abstract]","volume":"65","author":"Hartgring","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1111\/jth.13778_bb0220","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1136\/annrheumdis-2015-eular.6806","article-title":"A synerkine of IL4 and IL10 for inflammatory disorders [abstract]","volume":"74","author":"Hack","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1111\/jth.13778_bb0225","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1111\/j.1365-2141.2008.07278.x","article-title":"Interleukin\u201010 protects against blood\u2010induced joint damage","volume":"142","author":"Jansen","year":"2008","journal-title":"Br J Haematol"},{"key":"10.1111\/jth.13778_bb0230","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1182\/blood-2015-03-635524","article-title":"IL\u20101beta, in contrast to TNFalpha, is pivotal in blood\u2010induced cartilage damage and as such a potential target for therapy","volume":"126","author":"van Vulpen","year":"2015","journal-title":"Blood"},{"key":"10.1111\/jth.13778_bb0235","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1111\/jth.12176","article-title":"IL\u20106 receptor antagonist as adjunctive therapy with clotting factor replacement to protect against bleeding\u2010induced arthropathy in hemophilia","volume":"11","author":"Narkbunnam","year":"2013","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.13778_bb0240","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/jth.12101","article-title":"Nuclear factor (NF)\u2010kappaB and its associated pathways are major molecular regulators of blood induced joint damage in a murine model of hemophilia","volume":"11","author":"Sen","year":"2013","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.13778_bb0245","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/hae.12375","article-title":"The burden of bleeding in haemophilia: is one bleed too many?","volume":"20","author":"Gringeri","year":"2014","journal-title":"Haemophilia"},{"key":"10.1111\/jth.13778_bb0250","doi-asserted-by":"crossref","first-page":"4532","DOI":"10.1182\/blood-2008-01-131417","article-title":"Intraarticular factor IX protein or gene replacement protects against development of hemophilic synovitis in the absence of circulating factor IX","volume":"112","author":"Sun","year":"2008","journal-title":"Blood"},{"key":"10.1111\/jth.13778_bb0255","doi-asserted-by":"crossref","first-page":"492","DOI":"10.3390\/ijms17040492","article-title":"MicroRNA\u201015b modulates molecular mediators of blood induced arthropathy in hemophilia mice","volume":"17","author":"Sen","year":"2016","journal-title":"Int J Mol Sci"},{"key":"10.1111\/jth.13778_bb0260","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/j.1365-2559.2006.02508.x","article-title":"Synovitis score: discrimination between chronic low\u2010grade and high\u2010grade synovitis","volume":"49","author":"Krenn","year":"2006","journal-title":"Histopathology"},{"key":"10.1111\/jth.13778_bb0265","first-page":"204","article-title":"Inflammatory synovitis in degenerative joint disease","volume":"9","author":"Goldenberg","year":"1982","journal-title":"J Rheumatol"},{"key":"10.1111\/jth.13778_bb0270","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1182\/blood-2009-11-255174","article-title":"Sustained IL\u20104 exposure leads to a novel pathway for hemophagocytosis, inflammation, and tissue macrophage accumulation","volume":"116","author":"Milner","year":"2010","journal-title":"Blood"},{"key":"10.1111\/jth.13778_bb0275","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1002\/art.21104","article-title":"Interleukin\u20104 can be a key positive regulator of inflammatory arthritis","volume":"52","author":"Ohmura","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1111\/jth.13778_bb0280","first-page":"225","article-title":"TNF\u2010alpha antagonists augment factor replacement to prevent arthropathy in hemophilic mice [abstract]","volume":"7","author":"Sun","year":"2009","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.13778_bb0285","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1046\/j.1365-2516.1999.00347.x","article-title":"Assessing health\u2010related quality\u2010of\u2010life in individuals with haemophilia","volume":"5","author":"Miners","year":"1999","journal-title":"Haemophilia"},{"key":"10.1111\/jth.13778_bb0290","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1002\/art.20284","article-title":"Initiation of degenerative joint damage by experimental bleeding combined with loading of the joint: a possible mechanism of hemophilic arthropathy","volume":"50","author":"Hooiveld","year":"2004","journal-title":"Arthritis Rheum"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjth.13778","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622008686?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622008686?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/jth.13778\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T03:16:57Z","timestamp":1761535017000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622008686"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":57,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["S1538783622008686"],"URL":"https:\/\/doi.org\/10.1111\/jth.13778","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A fusion protein of interleukin\u20104 and interleukin\u201010 protects against blood\u2010induced cartilage damage in vitro and in vivo","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/jth.13778","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2017 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}